Response to Deucravacitinib in Psoriasis Patients with Prior Biologic Therapy Failures
Published: 8 October 2024| Version 1 | DOI: 10.17632/7shks5pmt3.1
Contributors:
Katie Lovell, Description
Demographics, disease site, disease duration, prior and adjunctive treatments, and duration of deucravacitinib treatment with overall response. Key: F = female; M = male; W = White; B = Black; MTX = methotrexate; CR = complete response; PR = partial response; NR = no response
Files
Institutions
Wake Forest University School of Medicine
Categories
Dermatology, Biologic Therapy, Psoriasis